Oxidative Stress in Patients With Early Stage Chronic Lymphocytic Leukemia, Assessment and Correlation With Prognostic Factors

Xavier Orti­n, Montserrat Giralt, Marta Romeu, Marylene Lejeune, M Rosa Nogues, Vanessa Sanchez-Martos, Marta Rodriguez-Luaces, Teresa Sans, Llorenç Font


Background: The heterogeneous clinical outcome that characterizes chronic lymphocytic leukemia (CLL) can be predicted by a serie of clinical prognosis factors. However, the existence of a significant subset of patients with early stage CLL makes crucial the need of more accurate prognostic markers allowing the possibility of early treatment of these patients. Although high reactive oxygen species (ROS) levels have been seen to play a role in CLL, discrepancies in the information compiled about oxidative stress (OS) in these patients have been reported.

Methods: In this study, we evaluate the overall OS status, through a recently defined score of oxidative stress (SOS), of 37 early stage CLL patients and we compare SOS with well-known prognosis factors and with a matched control group of healthy individuals.

Results: We have observed an imbalance in the antioxidant/prooxidant equilibrium in early stage CLL patients with a significant higher SOS than that of the healthy control group (0.00 ± 0.53 vs. 2.97 ± 1.13; P < 0.05). Most of the patients who exhibit 3 - 4 adverse prognosis factors also present higher values of most of the OS biomarkers and SOS.

Conclusions: These data strongly suggest that the combination strategy of OS biomarkers with already known prognosis factor may have potential clinical applications in early stage CLL patients.

doi: http://dx.doi.org/10.4021/jh34w


Chronic lymphocytic leukemia; Prognosis; Oxidative stress; Antioxidant enzymes; Lipid peroxidation

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics






Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.